<VariationArchive VariationID="6652" VariationName="NM_005677.4(COLQ):c.1082del (p.Pro361fs)" VariationType="Deletion" Accession="VCV000006652" Version="40" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="9" DateLastUpdated="2024-06-23" DateCreated="2015-05-01" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21691" VariationID="6652">
      <GeneList>
        <Gene Symbol="COLQ" FullName="collagen like tail subunit of asymmetric acetylcholinesterase" GeneID="8292" HGNC_ID="HGNC:2226" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="15450133" stop="15521706" display_start="15450133" display_stop="15521706" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="15491639" stop="15563257" display_start="15491639" display_stop="15563257" Strand="-" />
          </Location>
          <OMIM>603033</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005677.4(COLQ):c.1082del (p.Pro361fs)</Name>
      <CanonicalSPDI>NC_000003.12:15456011:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="15456012" stop="15456012" display_start="15456012" display_stop="15456012" variantLength="1" positionVCF="15456011" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="15497519" stop="15497519" display_start="15497519" display_stop="15497519" variantLength="1" positionVCF="15497518" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>P351fs</ProteinChange>
      <ProteinChange>P361fs</ProteinChange>
      <ProteinChange>P327fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.15497522del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.15497522del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.15456015del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.15456015del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009032.2" sequenceAccession="NG_009032" sequenceVersion="2" change="g.70740del">
            <Expression>NG_009032.2:g.70740del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005677.4" sequenceAccession="NM_005677" sequenceVersion="4" change="c.1082del" MANESelect="true">
            <Expression>NM_005677.4:c.1082del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005668.2" sequenceAccession="NP_005668" sequenceVersion="2" change="p.Pro361fs">
            <Expression>NP_005668.2:p.Pro361fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080538.2" sequenceAccession="NM_080538" sequenceVersion="2" change="c.1052del">
            <Expression>NM_080538.2:c.1052del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_536799.1" sequenceAccession="NP_536799" sequenceVersion="1" change="p.Pro351fs">
            <Expression>NP_536799.1:p.Pro351fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080539.4" sequenceAccession="NM_080539" sequenceVersion="4" change="c.980del">
            <Expression>NM_080539.4:c.980del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_536800.2" sequenceAccession="NP_536800" sequenceVersion="2" change="p.Pro327fs">
            <Expression>NP_536800.2:p.Pro327fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005677.3" sequenceAccession="NM_005677" sequenceVersion="3" change="c.1082delC">
            <Expression>NM_005677.3:c.1082delC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005677.4" sequenceAccession="NM_005677" sequenceVersion="4" change="c.1082delC" MANESelect="true">
            <Expression>NM_005677.4:c.1082delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA2275876" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603033.0005" DB="OMIM" />
        <XRef Type="rs" ID="769982050" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005677.4(COLQ):c.1082del (p.Pro361fs) AND Congenital myasthenic syndrome 5" Accession="RCV000007031" Version="16">
        <ClassifiedConditionList TraitSetID="1841">
          <ClassifiedCondition DB="MedGen" ID="C1864233">Congenital myasthenic syndrome 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-23" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005677.4(COLQ):c.1082del (p.Pro361fs) AND not provided" Accession="RCV000727941" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-07-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005677.4(COLQ):c.1082del (p.Pro361fs) AND Congenital myasthenic syndrome" Accession="RCV000825560" Version="5">
        <ClassifiedConditionList TraitSetID="9634">
          <ClassifiedCondition DB="MedGen" ID="C0751882">Congenital myasthenic syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-07-15" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005677.4(COLQ):c.1082del (p.Pro361fs) AND Abnormality of the musculature" Accession="RCV001813960" Version="1">
        <ClassifiedConditionList TraitSetID="24200">
          <ClassifiedCondition DB="MedGen" ID="C4021745">Abnormality of the musculature</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-23" NumberOfSubmissions="9" NumberOfSubmitters="9" DateCreated="2015-05-01" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10665486</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18180250</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21952943</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22088788</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22678886</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23371844</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24281389</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28464723</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29150079</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9689136</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=COLQ</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="1841" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1153" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Endplate acetylcholinesterase deficiency</ElementValue>
                <XRef ID="Endplate+acetylcholinesterase+deficiency/8313" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital myasthenic syndrome 5</ElementValue>
                <XRef ID="MONDO:0011281" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EAD</ElementValue>
                <XRef Type="MIM" ID="603034" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CMS5</ElementValue>
                <XRef Type="MIM" ID="603034" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18210" />
                <XRef ID="18210" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301347</ID>
                <ID Source="BookShelf">NBK1168</ID>
              </Citation>
              <XRef ID="590" DB="Orphanet" />
              <XRef ID="C1864233" DB="MedGen" />
              <XRef ID="MONDO:0011281" DB="MONDO" />
              <XRef Type="MIM" ID="603034" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9634" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9474" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital myasthenic syndrome</ElementValue>
                <XRef ID="MONDO:0018940" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11902" />
                <XRef ID="11902" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301347</ID>
                <ID Source="BookShelf">NBK1168</ID>
              </Citation>
              <XRef ID="590" DB="Orphanet" />
              <XRef ID="C0751882" DB="MedGen" />
              <XRef ID="D020294" DB="MeSH" />
              <XRef ID="MONDO:0018940" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS601462" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="24200" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="23481" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Abnormality of the musculature</ElementValue>
                <XRef ID="HP:0003011" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C4021745" DB="MedGen" />
              <XRef Type="primary" ID="HP:0003011" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003197" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003708" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27227" SubmissionDate="2015-04-27" DateLastUpdated="2015-05-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603033.0005_MYASTHENIC SYNDROME, CONGENITAL, 5" title="COLQ, 1-BP DEL, 1082C_MYASTHENIC SYNDROME, CONGENITAL, 5" />
        <ClinVarAccession Accession="SCV000027227" DateUpdated="2015-05-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-08-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1082delC mutation in the COLQ gene that was found in compound heterozygous state in a patient with congenital myasthenic syndrome-5 (CMS5; 603034) by Ohno et al. (1998), see 603033.0004.</Attribute>
              <Citation>
                <ID Source="PubMed">9689136</ID>
              </Citation>
              <XRef DB="OMIM" ID="603034" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient with CMS5, Ohno et al. (1998) identified homozygosity for the c.1082delC mutation. The asymptomatic parents were heterozygous for the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">9689136</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COLQ" />
          </GeneList>
          <Name>COLQ, 1-BP DEL, 1082C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1082C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603033.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYASTHENIC SYNDROME, CONGENITAL, 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1672445" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-16" DateCreated="2018-12-16">
        <ClinVarSubmissionID localKey="63393_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000855455" DateUpdated="2018-12-16" DateCreated="2018-12-16" Type="SCV" Version="1" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COLQ" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="-" referenceAllele="G" start="15497519" stop="15497519" variantLength="1" />
            <GeneLocation>NM_005677.3:Ex15</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD982556" />
            <XRef DB="dbSNP" ID="769982050" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=COLQ</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1894679" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="85005730|Orphanet:ORPHA590" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000966885" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9689136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22678886</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24281389</ID>
          </Citation>
          <Comment>The p.Pro361fs variant in COLQ has been reported in at least 8 individuals (2 co mpound heterozygotes and 6 homozygotes) with clinical features of congenital mya sthenic syndrome (Ohno 1998, Abicht 2012, Arredondo 2014). This variant has been identified in 0.004% (5/126540) of European chromosomes by the Genome Aggregati on Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs769982050). In vi tro functional studies provide some evidence that the p.Pro361fs variant may imp act protein function (Ohno 1998). This variant is predicted to cause a frameshif t, which alters the protein?s amino acid sequence beginning at position 361 and leads to a premature termination codon 65 amino acids downstream. This alteratio n is then predicted to lead to a truncated or absent protein. In summary, this v ariant meets criteria to be classified as pathogenic for congenital myasthenic s yndrome in an autosomal recessive manner based upon case studies, low frequency in controls, functional evidence, predicted impact on protein. ACMG/AMP Criteria applied: PVS1, PM2, PM3, PS3_P (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COLQ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_005677.3:EXON 15</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_005677.3:c.1082delC</Name>
            <Name>p.Pro361LeufsX65</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.15497519delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA590" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3453053" SubmissionDate="2021-09-09" DateLastUpdated="2022-01-22" DateCreated="2022-01-22">
        <ClinVarSubmissionID localKey="9616833|HPO:HP:0003011" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001755170" DateUpdated="2022-01-22" DateCreated="2022-01-22" Type="SCV" Version="1" SubmitterName="Kariminejad - Najmabadi Pathology &amp; Genetics Center" OrgID="506221" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COLQ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005677.3:c.1082delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0003011" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10350875</SubmissionName>
          <SubmissionName>SUB9989790</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5026548" SubmissionDate="2022-08-30" DateLastUpdated="2022-09-17" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="NM_005677.3:c.1082delC|MedGen:C0751882" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002570798" DateUpdated="2022-09-17" DateCreated="2022-09-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22678886</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9689136</ID>
          </Citation>
          <Comment>Variant summary: COLQ c.1082delC (p.Pro361LeufsX65) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been associated with Endplate acetylcholinesterase deficiency in HGMD and are classified as pathogenic in ClinVar. The variant allele was found at a frequency of 4.8e-05 in 251134 control chromosomes (gnomAD). c.1082delC has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Congenital Myasthenic Syndrome (examples: Ohno_1998 and Abicht_2012). Additionally, using in-vitro functional studies Ohno et al (1998) demonstrated that this variant affects protein function. These data indicate that the variant is very likely to be associated with disease. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COLQ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005677.3:c.1082delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751882" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11991162</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3966872" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="2689a4d880f22cecbf77b743903931f48a25663461512350e14c7fc5afb2f00e|OMIM:603034" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002019702" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005677.4:c.1082del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="603034" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8997438" SubmissionDate="2024-04-12" DateLastUpdated="2024-04-15" DateCreated="2024-04-15">
        <ClinVarSubmissionID localKey="rmh/unit_1/hg38_NM_005677_4_COLQ_c_1082delC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004812615" DateUpdated="2024-04-15" DateCreated="2024-04-15" Type="SCV" Version="1" SubmitterName="Molecular Genetics, Royal Melbourne Hospital" OrgID="508231" OrganizationCategory="laboratory" OrgAbbreviation="RMH" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9689136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10665486</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18180250</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21952943</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22088788</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22678886</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23371844</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29150079</ID>
          </Citation>
          <Comment>This sequence change in COLQ is a frameshift variant that may cause a premature stop codon, p.(Pro361Leufs*65), that is predicted to escape nonsense-mediated decay and remove &lt;10% of the protein, however, it is a truncation of a functionally important region (removes amino acids 416-433) in a gene where loss of function is an established disease mechanism (PMID: 9689136). The highest population minor allele frequency in the population database gnomAD v2.1 is 0.017% (6/35,406 alleles) in the Latino/Admixed American population, which is consistent with recessive disease. This variant has been detected in at least 15 individuals with congenital myasthenic syndrome. Of those individuals, 10 were homozygous and five were compound heterozygous for the variant and a pathogenic or likely pathogenic variant and two of those were confirmed in trans by family testing (PMID: 9689136, 10665486, 18180250, 21952943, 22088788, 22678886, 23371844, 29150079). Based on the classification scheme RMH Modified ACMG Guidelines v1.5.1, this variant is classified as PATHOGENIC. Following criteria are met: PM3_VeryStrong, PVS1_Strong, PM2_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COLQ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_20524</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005677.4:c.1082delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0011281" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_41</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3114566" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="3124961|MedGen:C1864233" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001588904" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9689136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23371844</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28464723</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 6652). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the COLQ protein in which other variant(s) (p.Cys427*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This premature translational stop signal has been observed in individuals with congenital myasthenic syndrome (PMID: 9689136, 23371844, 28464723). This variant is present in population databases (rs769982050, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Pro361Leufs*65) in the COLQ gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 95 amino acid(s) of the COLQ protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COLQ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.15497519del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1864233" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7866775" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_005677.4:c.1082del|OMIM:603034" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004214436" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005677.4:c.1082del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="603034" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="27227" TraitType="Disease" MappingType="Name" MappingValue="MYASTHENIC SYNDROME, CONGENITAL, 5" MappingRef="Preferred">
        <MedGen CUI="C1864233" Name="Congenital myasthenic syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8997438" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0011281" MappingRef="MONDO">
        <MedGen CUI="C1864233" Name="Congenital myasthenic syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5026548" TraitType="Disease" MappingType="XRef" MappingValue="C0751882" MappingRef="MedGen">
        <MedGen CUI="C0751882" Name="Congenital myasthenic syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3453053" TraitType="Disease" MappingType="XRef" MappingValue="HP:0003011" MappingRef="HP">
        <MedGen CUI="C4021745" Name="Abnormality of the musculature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3114566" TraitType="Disease" MappingType="XRef" MappingValue="C1864233" MappingRef="MedGen">
        <MedGen CUI="C1864233" Name="Congenital myasthenic syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3966872" TraitType="Disease" MappingType="XRef" MappingValue="603034" MappingRef="OMIM">
        <MedGen CUI="C1864233" Name="Congenital myasthenic syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7866775" TraitType="Disease" MappingType="XRef" MappingValue="603034" MappingRef="OMIM">
        <MedGen CUI="C1864233" Name="Congenital myasthenic syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1894679" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA590" MappingRef="Orphanet">
        <MedGen CUI="C0751882" Name="Congenital myasthenic syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1672445" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

